These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 9288574

  • 1. Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells.
    Solomon SS, Mishra SK, Cwik C, Rajanna B, Postlethwaite AE.
    Horm Metab Res; 1997 Aug; 29(8):379-82. PubMed ID: 9288574
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms involved in tumor necrosis factor-alpha induction of insulin resistance and its reversal by thiazolidinedione(s).
    Solomon SS, Usdan LS, Palazzolo MR.
    Am J Med Sci; 2001 Aug; 322(2):75-8. PubMed ID: 11523631
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA.
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [Abstract] [Full Text] [Related]

  • 7. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
    Sugiyama Y, Shimura Y, Ikeda H.
    Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
    [Abstract] [Full Text] [Related]

  • 8. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T.
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [Abstract] [Full Text] [Related]

  • 9. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, Kasuga M.
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [Abstract] [Full Text] [Related]

  • 10. Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats.
    Iida KT, Kawakami Y, Suzuki M, Shimano H, Toyoshima H, Sone H, Shimada K, Iwama Y, Watanabe Y, Mokuno H, Kamata K, Yamada N.
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1125-30. PubMed ID: 12569086
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K, Tomizawa H, Ishikawa J, Hoshide S, Numao T, Fukuda T, Shimada K, Kario K.
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [Abstract] [Full Text] [Related]

  • 12. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone.
    Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, Matsuyama S, Suzuki S, Kitamura KI, Sato N.
    J Pharmacol Exp Ther; 2003 Sep; 306(3):846-54. PubMed ID: 12805475
    [Abstract] [Full Text] [Related]

  • 13. Pioglitazone: mechanism of action.
    Smith U.
    Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
    [Abstract] [Full Text] [Related]

  • 14. Metformin and pioglitazone: Effectively treating insulin resistance.
    Staels B.
    Curr Med Res Opin; 2006 Sep; 22 Suppl 2():S27-37. PubMed ID: 16914073
    [Abstract] [Full Text] [Related]

  • 15. Metformin restores responses to insulin but not to growth hormone in Sprague-Dawley rats.
    Borst SE, Snellen HG, Ross H, Scarpace PJ, Kim YW.
    Biochem Biophys Res Commun; 2002 Mar 01; 291(3):722-6. PubMed ID: 11855850
    [Abstract] [Full Text] [Related]

  • 16. The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.
    Chen H, Ren A, Hu S, Mo W, Xin X, Jia W.
    Diabetes Res Clin Pract; 2007 Mar 01; 75(3):327-32. PubMed ID: 16930761
    [Abstract] [Full Text] [Related]

  • 17. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
    Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC.
    Clin Endocrinol (Oxf); 2007 Feb 01; 66(2):282-9. PubMed ID: 17224000
    [Abstract] [Full Text] [Related]

  • 18. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May 01; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 19. Neferine enhances insulin sensitivity in insulin resistant rats.
    Pan Y, Cai B, Wang K, Wang S, Zhou S, Yu X, Xu B, Chen L.
    J Ethnopharmacol; 2009 Jul 06; 124(1):98-102. PubMed ID: 19527823
    [Abstract] [Full Text] [Related]

  • 20. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H, Takeshita S, Yamamoto T, Mabuchi M, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Ita M, Mutoh S.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):182-90. PubMed ID: 16039648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.